Frank Low Research Day
The premier biomedical research event held annually at the UND School of Medicine & Health Sciences.
Named in honor of the former SMHS anatomy professor who came to UND in the 1960s and pioneered a series of new techniques for the electron microscope, Frank Low Research Day is the culminating event of the academic year for many area researchers working in the biomedical and health sciences.
Every year, more than 150 faculty members, postdoctoral fellows, and students present oral and/or poster presentations on a wide range of basic biomedical, health sciences, translational, and clinical topics. Poster presentations remain on display in the West Atrium on the first floor of the UND School of Medicine & Health Sciences.
Learn more about Frank Low in this 1999 article published in The Anatomical Record (No. 257: 48-49).
Frank Low Research Day 2021
The 41st Annual Frank Low Research Day will be held virtually on Thursday, April 22, 2021. Students and faculty in the basic sciences, health sciences, and clinical departments are encouraged to participate in the poster presentations.
Please contact Heather Jensen at email@example.com or 701.777,2516 with any questions.
This year’s virtual guest speaker is Dr. Eliezer Masliah. Eliezer Masliah, M.D., was named director of the Division of Neuroscience at the National Institute on Aging (NIA) in July, 2016. Before joining NIA, he held joint appointments in the departments of pathology and neurosciences at the University of California, San Diego (UCSD). As head of UCSD's Experimental Neuropathology Laboratory, he investigated synaptic damage in neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and AIDS-related dementia. His laboratory developed novel models of neurodegeneration as well as new gene therapies, small molecules and experimental immunotherapies for Alzheimer's disease and Parkinson's disease. Four of the experimental therapeutic approaches developed at his laboratory have now passed Phase I clinical trials. As the director of autopsy services at the UCSD Medical Center, he also directed the neuropathology core of the NIA-supported Shirley-Marcos Alzheimer's Disease Research Center.
More information coming soon!